Acute colitis pharmacology
Shorter-format studies designed around acute inflammatory disease activity and treatment response.
IMMUNOLOGY & INFLAMMATION MODEL
DSS-Induced Colitis Mouse Models
The documented inflammatory-bowel-disease platform includes DSS-induced acute and chronic colitis mouse models for preclinical pharmacology studies.
Strain, DSS regimen, acute or chronic format, treatment schedule, and readout package are confirmed during technical review.
MODEL OVERVIEW
Acute and chronic DSS colitis formats for IBD research.
DSS-induced mouse colitis can be configured around acute or chronic study objectives and combined with protocol-defined disease-activity, tissue, biomarker, and exposure measurements.
Therapeutic areaInflammatory bowel disease
SpeciesMouse
Model formatDSS acute, chronic colitis
Typical useEfficacy, Tissue, Biomarkers
TYPICAL APPLICATIONS
What this model can support.
Chronic colitis pharmacology
Chronic-format studies for programs requiring a longer inflammatory disease context.
Tissue analysis
Protocol-defined intestinal tissue collection for histology or downstream molecular analysis.
PK/PD & biomarkers
Exposure, pharmacodynamic, and biomarker measurements can be integrated when required by the program.
COMMON READOUTS
Readouts selected around the study question.
Endpoints are finalized with the selected model, species or strain, treatment design, and partner laboratory before study placement.
Disease activity
Protocol-defined clinical and disease-activity measures appropriate to the selected DSS format.
Tissue pathology
Intestinal tissue collection and histopathology when included in the study plan.
Biomarkers
Inflammatory or mechanism-linked biomarkers selected for the program.
Exposure
PK or tissue exposure measurements when required.
The source documentation confirms acute and chronic DSS mouse models but does not disclose a single standardized strain or induction regimen.
STUDY DESIGN
Key factors aligned before execution.
- Acute or chronic DSS format
- Mouse strain and study entry criteria
- Induction and treatment schedule
- Disease-activity assessment plan
- Histology and tissue outputs
- PK/PD and biomarker requirements
Discuss Your Program
Share the compound, mechanism, development question, preferred model, and intended endpoints. We can review fit, feasibility, and the appropriate partner-laboratory route for a DSS Colitis study.Required fields are marked with an asterisk(*).